Previous close | 1.3600 |
Open | 1.3200 |
Bid | 1.3600 x 4000 |
Ask | 1.3900 x 4000 |
Day's range | 1.3000 - 1.4400 |
52-week range | 0.7620 - 9.7500 |
Volume | |
Avg. volume | 4,888,731 |
Market cap | 739.778M |
Beta (5Y monthly) | -0.02 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.0500 |
Earnings date | 09 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 2.84 |
NEW YORK & MIAMI, May 30, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group," "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today announced that they have issued a presentation that outlines the urgent case for changes in leadership and strategy at the Company. The Group, which holds an approximately 35% equity stake in Cano, is
NEW YORK & MIAMI, May 25, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group," "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today announced that they have filed a definitive proxy statement with the U.S. Securities and Exchange Commission in order to solicit WITHHOLD votes against the re-election of Dr. Alan Muney, Chair of Cano
NEW YORK & MIAMI, May 18, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group," "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today announced that they have submitted a notice to the Company to nominate two highly qualified, independent candidates – Joseph Berardo, Jr. and Guy P. Sansone – for election to the Board of Directors (t
NEW YORK & MIAMI, May 11, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group", "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today issued the below letter to shareholders regarding its intended efforts at the 2023 Annual Meeting of Shareholders (the "Annual Meeting").
Cano Health, Inc. (CANO) delivered earnings and revenue surprises of 14.29% and 3.67%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
The Beauty Health Company (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cano Health, Inc. (CANO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK & MIAMI, April 26, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today issued the below letter to shareholders.
Humana, Viatris, agilon health and Cano Health are included in this Analyst Blog.
Growing patient volumes, admissions, health awareness and technological improvement in the first quarter are likely to have aided healthcare players like Humana (HUM), Viatris (VTRS), agilon health (AGL) and Cano Health (CANO).
NEW YORK & MIAMI, April 17, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today issued the following statement:
NEW YORK & MIAMI, April 10, 2023--Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE: CANO), today issued the below letter to fellow shareholders.
Cano Health, Inc. (CANO) delivered earnings and revenue surprises of 280% and 3.83%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Both Roku (NASDAQ: ROKU) and Cano Health (NYSE: CANO) are up more than 30%. Roku has been red hot in 2023, up an incredible 62% already. A big reason for Roku's struggles last year is that the company was unprofitable and the ad market simply wasn't strong.
The buyout of a competitor fueled a rise in the primary medical-care company's shares this week.
Shares of Cano Health (NYSE: CANO) fell 27.9% in December, according to data provided by S&P Global Market Intelligence. The company provides health and dental care management, with pharmacy services, home visits, telehealth, wellness activities, and transition care, mainly to Medicare Advantage members.
Shares of Cano Health (NYSE: CANO) were down as much as 35.6% this week and were still down 31.2% for the week as of late Thursday afternoon, according to data from S&P Global Intelligence. The stock fell even further after investment advisor Third Point, run by Dan Loeb, worried about Cano's liquidity, sold its remaining 3.5% stake in the company, according to a Bloomberg report. Cano, as of the third quarter, reported only $24 million in cash and cash equivalents.
What happened Cano Health (NYSE: CANO) saw its shares drop 46.9% last month. The company operates primary care and connected medical practices for seniors in Florida, Texas, Nevada and Puerto Rico. The company's stock closed October at $3.
Cano Health (NYSE: CANO), a value-based primary care provider, saw its shares drop 29.5% this week, according to data from S&P Global Market Intelligence. Its stock is likely to bounce back a little next week, as bargain hunters may flock to the stock now that it has hit a 52-week low.
Shares of Cano Health (NYSE: CANO) were crashing 31.6% lower as of 11:25 a.m. ET on Thursday. The steep decline came after the primary care provider announced its third-quarter results following the market close on Wednesday. The consensus among analysts surveyed by Refinitiv was for Cano to record a net loss of $0.05 per share.
Cano Health, Inc. (CANO) delivered earnings and revenue surprises of 75% and 6.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Yahoo Finance Live anchors discuss reports that CVS is now in exclusive talks to acquire Cano Health.
Yahoo Finance Live anchors discuss reports that Humana and CVS are interested in acquiring Cano Health.
FedEx, Costco, DocuSign are some of the trending stocks in after hours trading on Thursday, September 22, 2022.
Yahoo Finance's Seana Smith breaks down trending tickers moving in after hours trading.